Patients Deserve Price Tags Act

Hozzl · 2026-03-20T11:03:18Z

Explore the details of Senate Bill 2355 Patients Deserve Price Tags Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/20/2026, 11:03 AM

Summary of Bill S 2355

The bill introduced in the 119th Congress with the title "A bill to amend the Public Health Service Act to provide for hospital and insurer price transparency" focuses on enhancing transparency in hospital and insurer pricing. It aims to amend the Public Health Service Act with specific provisions related to price transparency within the healthcare system, potentially outlining requirements for hospitals and insurers to disclose pricing information to the public and consumers.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2355

Bill S 2355 is currently in the status of Bill Introduced since July 17, 2025. Bill S 2355 was introduced during Congress 119 and was introduced to the Senate on July 17, 2025. Bill S 2355's most recent activity was Committee on Health, Education, Labor, and Pensions. Hearings held. as of March 19, 2026

Bipartisan Support of Bill S 2355

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2355

Primary Policy Focus

Health

Alternate Title(s) of Bill S 2355

A bill to amend the Public Health Service Act to provide for hospital and insurer price transparency.

Comments

Zayla Hu

719

5 days ago

I don't think this bill is a good idea. It's going to make it harder for me to afford my medications. Why do they have to make things more complicated?

Raiden Thomson

788

4 days ago

I can't believe this bill is finally getting some attention. It's about time patients know what they're paying for when it comes to healthcare. This is a step in the right direction for transparency in the medical industry.